The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of CALGB 51101 (Alliance).
Tracy Batchelor
Honoraria - Oakstone Publishing
Consulting or Advisory Role - GenomiCare
Patents, Royalties, Other Intellectual Property - American Cancer Society; Oxford University Press; UpToDate
Sharmila Giri
No Relationships to Disclose
Amy S. Ruppert
Consulting or Advisory Role - Telios
Nancy L. Bartlett
Consulting or Advisory Role - Acerta Pharma; ADC Therapeutics; BTG; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Eric D. Hsi
Honoraria - Celgene; Jazz Pharmaceuticals; Seagen
Consulting or Advisory Role - Miltenyi Biotec
Research Funding - Abbvie (Inst); Cellerant Therapeutics (Inst); Lilly (Inst)
Bruce D. Cheson
Consulting or Advisory Role - Abbvie; Celgene; Epizyme; Gilead Sciences; Karyopharm Therapeutics; Morphosys; Parexel; Pharmacyclics/Janssen; SymBio Pharmaceuticals; TG Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - SymBio Pharmaceuticals
Lakshmi Nayak
Consulting or Advisory Role - Ono Pharmaceutical
Travel, Accommodations, Expenses - Bristol-Myers Squibb
John Paul Leonard
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Akcea Therapeutics; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Epizyme; Genentech/Roche; Genmab; Gilead Sciences; Incyte; Karyopharm Therapeutics; MEI Pharma; Merck; Miltenyi Biotec; Morphosys; Nordic Nanovector; Nordic Nanovector; Regeneron; Sandoz; Sutro Biopharma
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Celgene (Inst); Epizyme (Inst); Janssen Oncology (Inst); National Cancer Institute (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BeiGene
James L. Rubenstein
Consulting or Advisory Role - Kymera
Research Funding - Kymera